“Peptidyl Arginine Deiminase 4: APromising Therapeutic Target in Rheumatoid Arthritis and Other Diseases” (2025) Asian Journal of Pharmaceutics (AJP), 19(01). doi:10.22377/ajp.v19i01.6051.